Cited by 538RNA regulation and diseaseinterferon and immune responsesRNA Research and Splicing

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown

Open access

Chung, Hachung, Calis, Jorg J.A., Wu, Xianfang, Sun, Tony, Yu, Yingpu, Sarbanes, Stephanie L., Dao Thi, Viet Loan, Shilvock, Abigail R., Hoffmann, H.-Heinrich, Rosenberg, Brad R., Rice, Charles M.·2018·Cell

DOI 10.1016/j.cell.2017.12.038PMC PMC5831367

Open this paper in CoChat — free account Open PDF

Abstract

Type I interferon (IFN) is produced when host sensors detect foreign nucleic acids, but how sensors differentiate self from nonself nucleic acids, such as double-stranded RNA (dsRNA), is incompletely understood. Mutations in ADAR1, an adenosine-to-inosine editing enzyme of dsRNA, cause Aicardi-Goutières syndrome, an autoinflammatory disorder associated with spontaneous interferon production and neurologic sequelae. We generated ADAR1 knockout human cells to explore ADAR1 substrates and function. ADAR1 primarily edited Alu elements in RNA polymerase II (pol II)-transcribed mRNAs, but not putative pol III-transcribed Alus. During the IFN response, ADAR1 blocked translational shutdown by inhibiting hyperactivation of PKR, a dsRNA sensor. ADAR1 dsRNA binding and catalytic activities were required to fully prevent endogenous RNA from activating PKR. Remarkably, ADAR1 knockout neuronal progenitor cells exhibited MDA5 (dsRNA sensor)-dependent spontaneous interferon production, PKR activation, and cell death. Thus, human ADAR1 regulates sensing of self versus nonself RNA, allowing pathogen detection while avoiding autoinflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2017.12.038

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Self-citation
Repbase Update, a database of repetitive elements in eukaryotic genomes
Bao, W., Kojima, K. K., & Kohany, O. (2015) · Mobile DNA · doi:10.1186/s13100-015-0041-9 · Cited by 2,942

Show all 55 references

Sorted by citations

RIG-I-like receptors: their regulation and roles in RNA sensing
Rehwinkel, J., & Gack, M. U. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0288-3 · Cited by 1,770
Role of RNA modifications in cancer
Barbieri, I., & Kouzarides, T. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0253-2 · Cited by 1,350
Interferon-Stimulated Genes: What Do They All Do?
Schoggins, J. W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015756 · Cited by 1,036
Harnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature · doi:10.1038/s41586-018-0768-9 · Cited by 697
A-to-I RNA editing — immune protector and transcriptome diversifier
Eisenberg, E., & Levanon, E. Y. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0006-1 · Cited by 630
The type I interferonopathies: 10 years on
Crow, Y. J., & Stetson, D. B. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00633-9 · Cited by 489
The role of retrotransposable elements in ageing and age-associated diseases
Gorbunova, V., Seluanov, A., Mita, P., McKerrow, W., Fenyö, D., Boeke, J. D., Linker, S. B., Gage, F. H., Kreiling, J. A., Petrashen, A. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03542-y · Cited by 446
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Karki, R., Sundaram, B., Sharma, B. R., Lee, S., Malireddi, R. K. S., Nguyen, L. N., Christgen, S. L., Zheng, M., Wang, Y., Samir, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109858 · Cited by 444
Cellular origins of dsRNA, their recognition and consequences
Chen, Y. G., & Hur, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00430-1 · Cited by 457
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors
Onomoto, K., Onoguchi, K., & Yoneyama, M. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00602-7 · Cited by 440
Double-Stranded RNA Sensors and Modulators in Innate Immunity
Hur, S. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041356 · Cited by 420
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
Zhang, T., Yin, C., Fedorov, A., Qiao, L., Bao, H., Beknazarov, N., Wang, S., Gautam, A., Williams, R. M., Crawford, J. C., et al. (2022) · Nature · doi:10.1038/s41586-022-04753-7 · Cited by 420
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Yang, J., Xu, J., Wang, W. T., Zhang, B., Yu, X., & Shi, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01480-x · Cited by 412
Epigenetic regulation of the innate immune response to infection
Zhang, Q., & Cao, X. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0151-6 · Cited by 366
Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss
Liu, H., Golji, J., Brodeur, L. K., Chung, F. S., Chen, J. T., deBeaumont, R. S., Bullock, C., Jones, M. D., Kerr, G., Li, L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0302-5 · Cited by 359
Type I Interferons in Autoimmune Disease
Crow, M. K., Olferiev, M., & Kirou, K. A. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043952 · Cited by 320
A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
Dias, A. G., Sampaio, N. G., & Rehwinkel, J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.007 · Cited by 309
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency
Mehdipour, P., Marhon, S. A., Ettayebi, I., Chakravarthy, A., Hosseini, A., Wang, Y., de Castro, F. A., Loo Yau, H., Ishak, C., Abelson, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2844-1 · Cited by 304
Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation
Lee, H., Fenster, R. J., Pineda, S. S., Gibbs, W. S., Mohammadi, S., Davila-Velderrain, J., Garcia, F. J., Therrien, M., Novis, H. S., Gao, F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.021 · Cited by 279
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants
Dohlman, A. B., Mendoza, D. A., Ding, S., Gao, M. C., Dressman, H. K., Iliev, I. D., Lipkin, S. M., & Shen, X. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.12.001 · Cited by 287
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
Gannon, H., Zou, T., Kießling, M. K., Gao, G. F., Cai, D., Choi, P. S., Ivan, A. P., Buchumenski, I., Berger, A. C., Goldstein, J. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07824-4 · Cited by 250
ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation
de Reuver, R., Verdonck, S., Dierick, E., Nemegeer, J., Hessmann, E., Ahmad, S., Jans, M., Blancke, G., Nieuwerburgh, F. V., Botzki, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04974-w · Cited by 253
PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs
Kim, Y., Park, J., Kim, S., Kim, M. A., Kang, M., Kwak, C. S., Kang, M., Kim, B., Rhee, H., & Kim, V. N. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.029 · Cited by 247
Trial watch: TLR3 agonists in cancer therapy
Le Naour, J., Galluzzi, L., Zitvogel, L., Kroemer, G., & Vacchelli, E. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1771143 · Cited by 239
ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
Lamers, M. M., van den Hoogen, B. G., & Haagmans, B. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01763 · Cited by 224
ADAR1 mutation causes ZBP1-dependent immunopathology
Hubbard, N., Ames, J. M., Maurano, M. M., Chu, L. H., Somfleth, K. Y., Gokhale, N. S., Werner, M., Snyder, J. M., Lichauco, K., Savan, R., et al. (2022) · Nature · doi:10.1038/s41586-022-04896-7 · Cited by 219
Mechanisms and Regulation of RNA Condensation in RNP Granule Formation
Tauber, D., Tauber, G., & Parker, R. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.05.002 · Cited by 220
Regulation of long non-coding RNAs and genome dynamics by the RNA surveillance machinery
Nair, L., Chung, H., & Basu, U. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0209-0 · Cited by 203
Self-citation
In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
Katrekar, D., Chen, G., Meluzzi, D., Ganesh, A., Worlikar, A., Shih, Y.-R. V., Varghese, S., & Mali, P. (2019) · Nature Methods · doi:10.1038/s41592-019-0323-0 · Cited by 202
Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response
Wu, Y., Zhao, W., Liu, Y., Tan, X., Li, X., Zou, Q., Xiao, Z., Xu, H., Wang, Y., & Yang, X. (2018) · The EMBO Journal · doi:10.15252/embj.201899017 · Cited by 199
Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity
Roth, S. H., Levanon, E. Y., & Eisenberg, E. (2019) · Nature Methods · doi:10.1038/s41592-019-0610-9 · Cited by 193
Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs
Katrekar, D., Yen, J., Xiang, Y., Saha, A., Meluzzi, D., Savva, Y. A., & Mali, P. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01171-4 · Cited by 189
Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Bartok, E., & Hartmann, G. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.014 · Cited by 190
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
RNA modification: mechanisms and therapeutic targets
Qiu, L., Qian, J., Li, Y., & Han, J. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00139-x · Cited by 182
Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA–triggered innate immune responses
Samuel, C. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.004166 · Cited by 167
The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s
Tunbak, H., Enriquez-Gasca, R., Tie, C. H. C., Gould, P. A., Mlcochova, P., Gupta, R. K., Fernandes, L., Holt, J., van der Veen, A. G., Giampazolias, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19170-5 · Cited by 162
Cellular RNA surveillance in health and disease
Wolin, S. L., & Maquat, L. E. (2019) · Science · doi:10.1126/science.aax2957 · Cited by 152
ADAR RNA Modifications, the Epitranscriptome and Innate Immunity
Quin, J. E., Sedmík, J., Vukić, D., Khan, A., Keegan, L. P., & O’Connell, M. A. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.02.002 · Cited by 146
Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA
Paget, M., Cadena, C., Ahmad, S., Wang, H., Jordan, T. X., Kim, E., Koo, B., Lyons, S. M., Ivanov, P. V., tenOever, B. R., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.010 · Cited by 143
Self-Awareness: Nucleic Acid–Driven Inflammation and the Type I Interferonopathies
Uggenti, C., Lepelley, A., & Crow, Y. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041257 · Cited by 142
The role of RNA editing enzyme ADAR1 in human disease
Song, B., Shiromoto, Y., Minakuchi, M., & Nishikura, K. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1665 · Cited by 138
Programmable RNA sensing for cell monitoring and manipulation
Qian, Y., Li, J., Zhao, S., Matthews, E. A., Adoff, M., Zhong, W., An, X., Yeo, M., Park, C., Yang, X., et al. (2022) · Nature · doi:10.1038/s41586-022-05280-1 · Cited by 137
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Chen, D., Gu, X., Nurzat, Y., Xu, L., Li, X., Wu, L., Jiao, H., Gao, P., Zhu, X., Yan, D., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02089-6 · Cited by 127
ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation
de Reuver, R., Dierick, E., Wiernicki, B., Staes, K., Seys, L., Meester, E. D., Muyldermans, T., Botzki, A., Lambrecht, B. N., Nieuwerburgh, F. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109500 · Cited by 120
Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease
Tam, O. H., Ostrow, L. W., & Hammell, M. (2019) · Mobile DNA · doi:10.1186/s13100-019-0176-1 · Cited by 127
ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation
Hu, S.-B., Heraud-Farlow, J. E., Sun, T., Liang, Z., Goradia, A., Taylor, S., Walkley, C. R., & Li, J. B. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.018 · Cited by 121
Self-citation
Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses
Tang, Q., Rigby, R. E., Young, G. R., Hvidt, A. K., Davis, T., Tan, T. K., Bridgeman, A., Townsend, A., Kassiotis, G., & Rehwinkel, J. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.011 · Cited by 118
Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1
Maurano, M. M., Snyder, J. M., Connelly, C. F., Henao‐Mejia, J., Sidrauski, C., & Stetson, D. B. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.001 · Cited by 120
Stimulation of Innate Immunity by Host and Viral RNAs
Streicher, F., & Jouvenet, N. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.009 · Cited by 111
ADAR1 and its implications in cancer development and treatment
Baker, A. R., & Slack, F. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.03.013 · Cited by 111
RNA modification in cardiovascular disease: implications for therapeutic interventions
Wang, C., Hou, X., Guan, Q., Zhou, H., Li, Z., Liu, L., Liu, J., Li, F., Li, W., & Liu, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01638-7 · Cited by 111
The majority of A-to-I RNA editing is not required for mammalian homeostasis
Chalk, A. M., Taylor, S., Heraud-Farlow, J. E., & Walkley, C. R. (2019) · Genome biology · doi:10.1186/s13059-019-1873-2 · Cited by 107
ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity
Yu, H., Yang, B., Yang, J., Shi, X., Yang, X., Zhang, D., Zhao, D., Yan, W., Chen, L., Zheng, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810224 · Cited by 106
Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150
Pfaller, C. K., Donohue, R. C., Nersisyan, S. A., Brodsky, L., & Cattaneo, R. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006577 · Cited by 105
Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases
Okude, H., Ori, D., & Kawai, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625833 · Cited by 104
ADAR1 Editing and its Role in Cancer
Xu, L., & Öhman, M. (2018) · Genes · doi:10.3390/genes10010012 · Cited by 102
Treatments in Aicardi–Goutières syndrome
Crow, Y. J., Shetty, J., & Livingston, J. H. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14268 · Cited by 106
The Role of RNA Editing in Cancer Development and Metabolic Disorders
Kung, C.-P., Maggi, L. B., & Weber, J. D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00762 · Cited by 101
Cryo-EM Structures of MDA5-dsRNA Filaments at Different Stages of ATP Hydrolysis
Yu, Q., Qu, K., & Modis, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.012 · Cited by 101
Interferons in health and disease
Boehmer, D. F. R., & Zanoni, I. (2025) · Cell · doi:10.1016/j.cell.2025.06.044 · Cited by 112
Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation
Jiang, Q., Isquith, J. M., Zipeto, M., Diep, R. H., Pham, J., Santos, N. P. D., Reynoso, E., Chau, J., Leu, H. S., Lazzari, E., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.11.017 · Cited by 99
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Kung, C.-P., Cottrell, K. A., Ryu, S., Bramel, E. R., Kladney, R. D., Bao, E. A., Freeman, E. C., Sabloak, T., Maggi, L. B., & Weber, J. D. (2020) · Oncogene · doi:10.1038/s41388-020-01515-5 · Cited by 98
Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms
Sun, T., Yu, Y., Wu, X., Acevedo, A., Luo, J., Wang, J., Schneider, W. M., Hurwitz, B. S., Rosenberg, B. R., Chung, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021757118 · Cited by 98
Self-citation
Evolution and antiviral activity of a human protein of retroviral origin
Frank, J. A., Singh, M., Cullen, H. B., Kirou, R. A., Benkaddour-Boumzaouad, M., Cortés, J. L., Pérez, J. G., Coyne, C. B., & Feschotte, C. (2022) · Science · doi:10.1126/science.abq7871 · Cited by 99
ADAR1: from basic mechanisms to inhibitors
Rehwinkel, J., & Mehdipour, P. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.06.006 · Cited by 99
Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells
Chua, B. A., van der Werf, I. M., Jamieson, C. H. M., & Signer, R. A. J. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.01.005 · Cited by 96
Inhibition of PKR by Viruses
Cesaro, T., & Michiels, T. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757238 · Cited by 93
Sensing of transposable elements by the antiviral innate immune system
Gázquez-Gutiérrez, A., Witteveldt, J., Heras, S. R., & Macías, S. (2021) · RNA · doi:10.1261/rna.078721.121 · Cited by 101
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 94
Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections
Pfaller, C. K., George, C. X., & Samuel, C. E. (2021) · Annual Review of Virology · doi:10.1146/annurev-virology-091919-065320 · Cited by 89
RNA Modification in the Immune System
Han, D., & Xu, M. M. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-045401 · Cited by 90
RNA Recognition and Immunity—Innate Immune Sensing and Its Posttranscriptional Regulation Mechanisms
Uehata, T., & Takeuchi, O. (2020) · Cells · doi:10.3390/cells9071701 · Cited by 88
On the origin and evolution of RNA editing in metazoans
Zhang, P., Zhu, Y., Guo, Q., Li, J., Zhan, X., Yu, H., Xie, N., Tan, H., Lundholm, N., Garcia‐Cuetos, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112112 · Cited by 88
The competitive landscape of the dsRNA world
Cottrell, K. A., Andrews, R. J., & Bass, B. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.033 · Cited by 88
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Sievers, B. L., Cheng, M. T. K., Csiba, K., Meng, B., & Gupta, R. K. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01104-y · Cited by 91
ADARs act as potent regulators of circular transcriptome in cancer
Shen, H., An, Ö., Ren, X., Song, Y., Tang, S. J., Ke, X., Han, J., Tay, D. J. T., Ng, V. H. E., Molías, F. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29138-2 · Cited by 86
Increased adenosine-to-inosine RNA editing in rheumatoid arthritis
Vlachogiannis, N. I., Gatsiou, A., Silvestris, D. A., Stamatelopoulos, K. S., Tektonidou, M. G., Gallo, A., Sfikakis, P. P., & Stellos, K. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102329 · Cited by 81
Primate-restricted KRAB zinc finger proteins and target retrotransposons control gene expression in human neurons
Turelli, P., Playfoot, C. J., Grun, D., Raclot, C., Pontis, J., Coudray, A., Thorball, C. W., Duc, J., Pankevich, E. V., Deplancke, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3200 · Cited by 85
Emerging role of RNA modification N6-methyladenosine in immune evasion
Lou, X., Wang, J.-J., Wei, Y., & Sun, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03585-z · Cited by 80
Mitochondrial double-stranded RNAs govern the stress response in chondrocytes to promote osteoarthritis development
Kim, S., Lee, K., Choi, Y. S., Ku, J., Kim, H., Kharbash, R., Yoon, J., Lee, Y. S., Kim, J., Lee, Y. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111178 · Cited by 79
The Immunological Conundrum of Endogenous Retroelements
Kassiotis, G. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-033341 · Cited by 81
L1 retrotransposition in the soma: a field jumping ahead
Faulkner, G. J., & Billon, V. (2018) · Mobile DNA · doi:10.1186/s13100-018-0128-1 · Cited by 85
OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug
Banerjee, S., Gusho, E., Gaughan, C., Dong, B., Gu, X., Holvey-Bates, E. G., Talukdar, M., Li, Y., Weiss, S. R., Sicheri, F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815071116 · Cited by 79
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
Giordano, A. M. S., Luciani, M., Gatto, F., Abou Alezz, M., Beghè, C., Della Volpe, L., Migliara, A., Valsoni, S., Genua, M., Dzieciatkowska, M., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211121 · Cited by 76
Human MYC G-quadruplex: From discovery to a cancer therapeutic target
Wang, W., Hu, S., Gu, Y., Yan, Y., Stovall, D. B., Li, D., & Sui, G. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188410 · Cited by 79
ADAR1: A New Target for Immuno-oncology Therapy
Bhate, A., Sun, T., & Li, J. B. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.021 · Cited by 74
Self-citation
Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR
Zhou, S., Yang, C., Zhao, F., Huang, Y., Lin, Y., Huang, C., Ma, X., Du, J., Wang, Y., Long, G., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009113 · Cited by 74
Long 3′UTRs predispose neurons to inflammation by promoting immunostimulatory double-stranded RNA formation
Dorrity, T. J., Shin, H., Wiegand, K. A., Aruda, J., Closser, M., Jung, E., Gertie, J. A., Leone, A., Polfer, R., Culbertson, B., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg2979 · Cited by 76
Self-citation
2′-O-methylation at internal sites on mRNA promotes mRNA stability
Li, Y., Yang, Y., Gao, X., Wang, X., Zhao, D., Wang, R., Zhang, L., Gao, B., Zhang, Y., Zhang, L., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.04.011 · Cited by 79
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Liu, J., & Cao, X. (2023) · Cell Research · doi:10.1038/s41422-022-00752-5 · Cited by 74
RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain
Kim, J. I., Nakahama, T., Yamasaki, R., Cruz, P. H. C., Vongpipatana, T., Inoue, M., Kanou, N., Xing, Y., Todo, H., Shibuya, T., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009516 · Cited by 72
A tale of two proteins: PACT and PKR and their roles in inflammation
Chukwurah, E., Farabaugh, K. T., Guan, B., Ramakrishnan, P., & Hatzoglou, M. (2021) · FEBS Journal · doi:10.1111/febs.15691 · Cited by 73
Repetitive elements in aging and neurodegeneration
Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70
The role of CSDE1 in translational reprogramming and human diseases
Guo, A.-X., Cui, J., Wang, L., & Yin, J. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0496-2 · Cited by 73
The 14-3-3η chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution
Lin, J.-P., Fan, Y.-K., & Liu, H. M. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007582 · Cited by 69
Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
Mustelin, T., Lood, C., & Giltiay, N. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01028 · Cited by 69
Recognition of non-CpG repeats in Alu and ribosomal RNAs by the Z-RNA binding domain of ADAR1 induces A-Z junctions
Nichols, P. J., Bevers, S. G., Henen, M. A., Kieft, J. S., Vicens, Q., & Vögeli, B. (2021) · Nature Communications · doi:10.1038/s41467-021-21039-0 · Cited by 68
Novel insights into double-stranded RNA-mediated immunopathology
de Reuver, R., & Maelfait, J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00940-3 · Cited by 70

Authors: Chung, H., Calis, J. J. A., Wu, X., Sun, T., Yu, Y., Sarbanes, S. L., Dao Thi, V. L., Shilvock, A. R., Hoffmann, H.-H., Rosenberg, B. R., & Rice, C. M.
Affiliations: Rockefeller University (US)
Corresponding author: Rice, Charles M.
ORCID: Chung, Hachung
Calis, Jorg J.A.
Wu, Xianfang
Sun, Tony
Yu, Yingpu
Sarbanes, Stephanie L.
Shilvock, Abigail R.
Hoffmann, H.-Heinrich
Rosenberg, Brad R.
Rice, Charles M.
Venue: Cell
Publisher: Elsevier BV
Published: 2018-02
Volume: 172
Issue: 4
Pages: 811-824.e14
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2017.12.038
PMC: PMC5831367
OpenAlex: W2784970793
Cited by: 538
References: 55
Citations by year: 2026: 53 · 2025: 69 · 2024: 67 · 2023: 71 · 2022: 64 · 2021: 74 · 2020: 60 · 2019: 44 · 2018: 36
FWCI: 19.03
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 372 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: NIAID/NIH (R01-AI091707, F32AI114211)
John C. Whitehead Presidential Fellowship
Netherlands Organization for Scientific Research
Helmsley postdoctoral fellowship
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords: ADAR1, Aicardi-Goutières syndrome, type I interferon, dsRNA sensing, PKR, MDA5, Alu elements, RNA editing, autoinflammation, neural progenitor cells, cell death, RNA polymerase II transcripts
MeSH terms: Interferon-Induced Helicase, IFIH1, Adenosine Deaminase, Humans, Inflammation, Nervous System Malformations, RNA Polymerase II, RNA, Double-Stranded, Protein Biosynthesis, RNA-Binding Proteins, Cell Death, eIF-2 Kinase, Alu Elements, Autoimmune Diseases of the Nervous System, Gene Knockout Techniques, HEK293 Cells, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks